跳至主要内容
临床试验/DRKS00024861
DRKS00024861已完成未知

Randomized controlled trial to evaluate the digital health application My Dose Coach

Sanofi-Aventis Deutschland GmbH0 个研究点目标入组 251 人开始时间: 2021年4月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
251

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Diagnosed type 2 diabetes (E11)
  • - Indication for therapy with basal insulin in combination with oral antidiabetic agents
  • - Age = 18 years
  • - HbA1c value> 7.5% or 58.5 mmol / mol and <10.0% or 85.6 mmol / mol (last measured HbA1c value from the patient file)
  • - Use of a smartphone compatible with the My Dose Coach app (iPhone models 5 and higher with iOS 10 or higher; Android version 4.4 or higher)
  • - Willingness to consent to the terms and conditions of the My Dose Coach app
  • - Knowledge of German, spoken and written
  • - Existence of a written declaration of consent for participation in the study

排除标准

  • - Treatment with prandial insulin (mealtime insulin)
  • - Body Mass Index (BMI) <25 kg / m2
  • - Renal insufficiency (GFR <30 ml / min)
  • - The presence of an acute psychiatric illness which, in the opinion of the investigator, affects the patient's ability to properly carry out the diabetes therapy or the study
  • - Use of another titration app
  • - Lack of consent due to limited legal capacity or legal support
  • - Dependency on the sponsor or the clinical investigator (e.g. employees of the sponsor or a trial center and their family members)
  • - Simultaneous participation in another clinical study

研究者

相似试验